Trial Profile
Phase 3 study in tremor.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 12 Oct 2018
Price :
$35
*
At a glance
- Drugs Suvecaltamide (Primary)
- Indications Tremor
- Focus Therapeutic Use
- 12 Oct 2018 New trial record